US Stock MarketDetailed Quotes
ELOX Eloxx Pharmaceuticals
- 0.000
- 0.000-99.00%
15min DelayTrading Dec 11 10:04 ET
3.14Market Cap0.00P/E (TTM)
0.000High0.000Low3.41KVolume0.000Open0.000Pre Close0.00Turnover0.12%Turnover Ratio0.00P/E (Static)3.14MShares1.74052wk High0.00P/B2.77Float Cap0.00052wk Low--Dividend TTM2.77MShs Float984.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Eloxx Pharmaceuticals Company
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Watertown, MA.
Company Profile
SymbolELOX
Company NameEloxx Pharmaceuticals
Listing DateApr 26, 2018
Founded2017
CEOMr. Sumit Aggarwal
MarketPink Market
Employees18
Fiscal Year Ends12-31
Address480 Arsenal Way,Suite 130
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-577-5300
Websitehttp://www.eloxxpharma.com
Company Executives
- Name
- Position
- Salary
- Sumit Aggarwal
- Director, President and Chief Executive Officer
- 1.40M
- Daniel E. Geffken, M.B.A.
- Interim Chief Financial Officer and Principal Accounting Officer
- 63.96K
- Tomer Kariv
- Chairman of the Board
- 51.10K
- Steven D. Rubin
- Independent Director
- 58.60K
- Lindsay Androski
- Independent Director
- 34.30K
- Dr. Alan Walts
- Independent Director
- 61.10K
Heat List
US
Overall
Symbol
Price
% Chg
No Data